BARCLAYS PLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 113 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2021$62,000
-8.8%
101,986
+55.4%
0.00%
Q3 2021$68,000
-38.7%
65,612
+7.6%
0.00%
Q2 2021$111,000
-11.9%
60,994
-5.0%
0.00%
Q1 2021$126,000
+186.4%
64,217
+160.7%
0.00%
Q3 2020$44,000
-85.6%
24,629
-32.5%
0.00%
Q2 2020$305,000
+510.0%
36,465
+276.2%
0.00%
Q1 2020$50,0009,692
+8874.1%
0.00%
Q4 2019$0
-100.0%
108
-99.7%
0.00%
Q3 2019$179,000
-64.1%
36,705
-49.0%
0.00%
Q2 2019$499,000
+13.4%
71,995
+13.7%
0.00%
Q1 2019$440,000
+746.2%
63,306
+600.2%
0.00%
Q4 2018$52,000
+5100.0%
9,041
+5967.8%
0.00%
Q3 2018$1,000
-98.1%
149
-98.6%
0.00%
Q2 2018$54,000
-68.6%
10,899
-61.5%
0.00%
Q1 2018$172,000
+186.7%
28,302
+237.5%
0.00%
Q4 2017$60,000
-70.0%
8,385
-70.1%
0.00%
Q3 2017$200,000
+163.2%
28,001
+132.7%
0.00%
Q2 2017$76,000
-78.0%
12,031
-71.2%
0.00%
Q1 2017$345,000
-76.5%
41,777
-76.0%
0.00%
-100.0%
Q4 2016$1,470,000173,9870.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$6,307,0004.30%
ETF MANAGERS GROUP, LLC 8,103,641$10,130,0000.22%
AdvisorShares Investments LLC 271,873$340,0000.08%
Platform Technology Partners 60,000$75,0000.04%
PINNACLE ASSOCIATES LTD 942,079$1,178,0000.02%
HRT FINANCIAL LP 883,510$1,104,0000.02%
Virtu Financial LLC 153,908$192,0000.02%
Tekla Capital Management LLC 413,481$517,0000.02%
Aries Wealth Management 23,400$33,0000.02%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 56,932$71,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders